News
The McNutt Lab translates mechanistic findings on chemical and neurotoxicity into new therapies for hard-to-treat injuries. Here we share research highlights, press coverage, and updates from the lab.
2022
Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are investigating a drug used to treat neuromuscular weakness as a potential treatment for botulism, a rare but serious disease.
2021
Two research groups have designed chimeric fusion proteins that constitute a new “trojan horse” approach to neutralize lethal botulinum toxins.
Related to new research published in the January issue of Science Translational Medicine, Patrick McNutt, PhD, of the Wake Forest Institute for Regenerative Medicine, was part of the research team that demonstrated a new “Trojan horse” approach that produces strong antidotal efficacy in treating lethal botulism in mice, guinea pigs and rhesus macaque monkeys.
2015
Army scientist discusses medical research being carried out to understand and protect against warfare agents